Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIMPLE: Liraglutide + Basal Insulin vs Basal-Bolus in T2D
NCT01966978Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Nov 2014
- Primary completion
- Dec 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by UT Southwestern Medical Center. Started Nov 2014; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01966978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01966978.